EC Gynaecology

Research Article Volume 13 Issue 2 - 2024

Prospective Study on the Efficacy and Safety of Uronext® in Parallel Groups in Women with Acute Cystitis

Khodyreva LA1,2, Bernikov AN1,3, Kupriyanov YA1,2,3, Arefieva OA1,2,3, Orešnik M4* and Pushkar DY1,2,3

11Moscow Urological Center on the Basis of Botkin Hospital, Russia

12Research Institute of the Moscow Department of Health, Russia

2Krasnoyarsk Regional Clinical Center of Maternity and Childhood, Krasnoyarsk, Russian Federation

*Corresponding Author: Tskhay VB, Department of Medical Faculty, Prof. V. F. Voino-Yasenetsky Krasnoyarsk State Medical University and Krasnoyarsk Regional Clinical Center of Maternity and Childhood, Krasnoyarsk, Russian Federation.
Received: November 28, 2023; Published: December 15, 2023

Uterine sarcoma is significantly rarer than leiomyoma and has poor prognosis. Moreover, leiomyosarcoma is difficult to be diagnosed due to its symptoms, including pelvic pain, uterine mass, and/or uterine bleeding, are very similar to those of leiomyoma. There are a few cases of leiomyosarcoma wherein leiomyoma was treated with uterine artery embolization (UAE). We describe a case of a 44-year-old woman diagnosed with leiomyosarcoma 3 months after undergoing UAE for multiple leiomyomas.

 Keywords: Leiomyoma; Uterine Sarcoma; Leiomyosarcoma; Uterine Artery Embolization

Tskhay VB., et al. "Uterine Leiomyosarcomas Occurring in a Patient After Uterine Artery Embolization: A Case Report". EC Gynaecology 13.2 (2024): 01-13.